|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
01093 CSPC PHARMA
Nominal 
8.210 +0.460 (+5.935%) | 2022/06 - Interim RMB(K¥) | %Chg (Interim to Interim) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | 2019/12 RMB(K¥) | 2018/12 RMB(K¥) | ||
| Turnover | 15,610,026 | 12.934% | 27,866,870 | 24,942,204 | 22,103,192 | 17,716,540 | |
| Cost of Sales | (4,271,542) | 29.534% | (6,731,776) | (6,256,882) | (6,192,211) | (5,979,187) | |
| Gross Profit | 11,338,484 | 7.732% | 21,135,094 | 18,685,322 | 15,910,981 | 11,737,353 | |
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) on Disposal | -- | -- | 37,365 | 333,055 | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | 823 | -46.903% | 22,443 | 13,532 | 58,407 | 43,554 | |
| Profit / (Loss) before Taxation | 3,719,460 | 1.545% | 6,847,096 | 6,391,023 | 4,626,162 | 3,792,179 | |
| Taxation | (692,377) | 25.030% | (1,158,972) | (1,162,013) | (892,810) | (733,760) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | (60,878) | 30.802% | (82,939) | (69,355) | (19,246) | 22,383 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | 2,966,205 | -3.147% | 5,605,185 | 5,159,655 | 3,714,106 | 3,080,802 | |
| Net Finance Costs / (Income) | (88,753) | 26.387% | (175,576) | (90,588) | (32,314) | 21,267 | |
| Depreciation & Amortisation | 481,634 | 11.883% | 865,471 | 808,807 | 691,595 | 629,848 | |
| Directors' Emoluments | -- | -- | 54,944 | 49,952 | 49,097 | 42,733 | |
| Auditor's Opinion Status | N/A | -- | Unqualified | Unqualified | Unqualified | Unqualified | |
Market Valuation Indicators
| EPS (cts) | 24.890 | -- | 46.890 | 43.160 | 31.070 | 25.708 |
| DPS (cts) | 8.715 | -- | 14.959 | 10.678 | 9.464 | 8.214 |
| Dividend Payout Ratio (%) | 35.015% | -- | 31.902% | 24.741% | 30.461% | 31.952% |
| Cash flow per share ($) | -- | -- | 0.388 | 0.564 | 0.317 | 0.317 |
| NBV per share ($) | 2.350 | -- | 2.175 | 1.865 | 1.542 | 1.257 |
| Remarks: | Real time quote last updated: 21/03/2023 11:56 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 2,966,205 |
| %Change | -3.147% |
| EPS / (LPS) | RMB 0.249 |
| NBV Per Share (¥) | RMB 2.350 |